Clinical trials
Terminated Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2011 | 5 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 5 |
| 2022 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 5 |
| Fudan University | 4 |
| Shanghai Jiao Tong University School of Medicine | 3 |
| Hoffmann-La Roche | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Pfizer | 2 |
| Ruijin Hospital | 2 |
| Sanofi | 2 |
| Accutar Biotechnology Inc | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 39 |
| Triple Negative Breast Neoplasms | 5 |
| Bone Diseases, Metabolic | 1 |
| Brain Neoplasms | 1 |
| Bulbo-Spinal Atrophy, X-Linked | 1 |
| Chemotherapy-Related Cognitive Impairment | 1 |
| Cognitive Dysfunction | 1 |
| Endometrial Neoplasms | 1 |
| Gangliosidoses | 1 |
| Gangliosidosis, GM1 | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.